OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A systematic review of health-related quality of life outcomes in patients with advanced breast cancer treated with palbociclib
Imtiaz A. Samjoo, Alexandra Hall, Connie Chen, et al.
Journal of Comparative Effectiveness Research (2024) Vol. 13, Iss. 10
Open Access | Times Cited: 5
Imtiaz A. Samjoo, Alexandra Hall, Connie Chen, et al.
Journal of Comparative Effectiveness Research (2024) Vol. 13, Iss. 10
Open Access | Times Cited: 5
Showing 5 citing articles:
Real-world effectiveness of CDK4/6i in first-line treatment of HR+/HER2− advanced/metastatic breast cancer: updated systematic review
Nadia Harbeck, Adam Brufsky, Christopher M. Rose, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Nadia Harbeck, Adam Brufsky, Christopher M. Rose, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Effect of palbociclib plus letrozole on patient-reported health-related quality of life: extended follow-up of the PALOMA-2 trial
Nadia Harbeck, Véronique Dièras, Karen A. Gelmon, et al.
ESMO Open (2025) Vol. 10, Iss. 4, pp. 104497-104497
Closed Access
Nadia Harbeck, Véronique Dièras, Karen A. Gelmon, et al.
ESMO Open (2025) Vol. 10, Iss. 4, pp. 104497-104497
Closed Access
Preliminary investigation on the mechanism of baicalein regulating the effects of Nischarin on invasion and apoptosis of human breast cancer cells MCF-7 through Wnt3α/β-catenin pathway
Gaojian He, Xuemei Huang, Yun Dong, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113262-113262
Closed Access | Times Cited: 2
Gaojian He, Xuemei Huang, Yun Dong, et al.
International Immunopharmacology (2024) Vol. 143, pp. 113262-113262
Closed Access | Times Cited: 2
Real-world quality-of-life of patients with HR+/HER2− advanced breast cancer treated with palbociclib plus endocrine therapy: EORTC QLQ-C30 results from POLARIS
Gabrielle B. Rocque, Joanne L. Blum, Yan Ji, et al.
Breast Cancer Research and Treatment (2024) Vol. 209, Iss. 3, pp. 613-627
Open Access | Times Cited: 1
Gabrielle B. Rocque, Joanne L. Blum, Yan Ji, et al.
Breast Cancer Research and Treatment (2024) Vol. 209, Iss. 3, pp. 613-627
Open Access | Times Cited: 1
Palbociclib as an Antitumor Drug: A License to Kill
Agnieszka Łupicka‐Słowik, Federica Cossu, Marcin Sieńczyk
Molecules (2024) Vol. 29, Iss. 22, pp. 5334-5334
Open Access
Agnieszka Łupicka‐Słowik, Federica Cossu, Marcin Sieńczyk
Molecules (2024) Vol. 29, Iss. 22, pp. 5334-5334
Open Access
